A population-scale atlas of blood and tissue in lupus nephritis
Nicholas W. SugiartoiD, Siddarth GurajalaiD, Michelle L. CurtisiD, Thomas EisenhaureiD, Arnon AraziiD, Andrea FavaiD, Qian XiaoiD, Joseph MearsiD, Brad H. RoviniD, Céline C. BerthieriD, Yu Zhao, Peter IzmirlyiD, Jennifer L. BarnasiD, Paul J. Hoover, Michael Peters, Raktima Raychowdhury, Alice HorisbergeriD, Saori SakaueiD, Richard Alan FurieiD, Michael H BelmontiD, David A. HildemaniD, E. Steve WoodleiD, Maria Dall’EraiD, Chaim PuttermaniD, Diane L. KameniD, , Soumya RaychaudhuriiD
Abstract
One Sentence SummaryA single-cell atlas of paired blood and tissue samples from Lupus Nephritis patients and healthy controls identified stromal and immune populations within renal tissue, including the scar-associated macrophage populations, which correlate with and may drive renal disease activity. Lupus nephritis (LN), a severe manifestation of Systemic Lupus Erythematosus (SLE), is a heterogeneous disease driven by diverse immune and tissue cell types. We obtained 538K single-cell and 140K single-nuclear profiles from kidney biopsies of 155 LN patients and 30 pre-implantation transplant biopsy controls, along with 325K single-cell blood profiles overlapping many of these patients. We identified key tissue cell types and cell states, and immune cell states; we were able to determine cell states that were tissue specific, and those that were present in the blood. We observed that LN pathological features are significantly associated with cell states using differential gene expression and Covarying Neighborhood Analysis (CNA). These analyses revealed broad changes in cell states associated with irreversible chronic tissue damage. After controlling for the effects of ongoing tissue damage, we observed that expansion of key glomerular and Scar Associated Macrophages (SAMs) populations tracked with increasing inflammatory disease activity. SAMs appear to drive LN fibrosis and, in active disease, infiltrate the glomeruli more than other myeloid cells. These observations strongly support that therapeutic targeting of myeloid populations may offer an as-of-yet unproven strategy to prevent renal inflammation and ongoing kidney damage in LN.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression
Paul Hoover, Thomas Eisenhaure, … Arnon Arazi·Annals of the Rheumatic DiseasesPeer-reviewed·Apr 28, 2026
- The immune cell landscape in kidneys of lupus nephritis patients
A. Arazi, D. A. Rao, … B. Diamond·bioRxiv·Jul 7, 2018
- Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis
Alice Horisberger, Alec M. Griffith, … Deepak A. Rao·Journal of Clinical InvestigationPeer-reviewed·Jun 19, 2025
- Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis
Chirag Raparia, Paul Hoover, … Anne Davidson·Annals of the Rheumatic DiseasesPeer-reviewed·Aug 1, 2026
- Intrarenal myeloid subsets associated with kidney injury are comparable in mice and patients with lupus nephritis
P. Hoover, D. J. Lieb, … A. Davidson·bioRxiv·Jun 24, 2023
- Insights from Comparison of the Renal and Skin Single Cell Transcriptomes in Lupus Nephritis
E. Der, H. Suryawanshi, … C. Putterman·bioRxiv·Dec 31, 2019